Renaissance Technologies - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$49,517
-21.5%
1,613,997
+2.5%
0.08%
-7.7%
Q2 2023$63,098
-0.8%
1,574,697
+1.0%
0.09%
+8.3%
Q1 2023$63,619
+3.8%
1,558,897
-1.8%
0.08%0.0%
Q4 2022$61,278
-99.9%
1,587,097
-9.5%
0.08%
-36.4%
Q3 2022$93,269,000
-18.6%
1,753,497
-10.8%
0.13%
-2.9%
Q2 2022$114,588,000
-19.3%
1,965,497
+5.6%
0.14%
-18.6%
Q1 2022$142,031,000
+27.6%
1,860,997
+0.6%
0.17%
+21.0%
Q4 2021$111,266,000
+0.9%
1,849,197
-6.1%
0.14%
-2.8%
Q3 2021$110,253,000
-11.8%
1,968,797
-4.4%
0.14%
-9.0%
Q2 2021$125,021,000
-22.9%
2,060,327
-11.0%
0.16%
-22.8%
Q1 2021$162,244,000
+3.3%
2,314,797
-11.8%
0.20%
+18.1%
Q4 2020$157,084,000
-6.0%
2,625,059
-5.6%
0.17%
+2.4%
Q3 2020$167,139,000
+11.7%
2,780,097
-2.5%
0.17%
+29.5%
Q2 2020$149,581,000
+80.7%
2,850,797
+15.5%
0.13%
+61.2%
Q1 2020$82,757,000
+1.6%
2,468,142
+37.3%
0.08%
+27.0%
Q4 2019$81,419,000
+76.0%
1,797,338
+47.9%
0.06%
+61.5%
Q3 2019$46,259,000
-2.6%
1,215,100
+11.3%
0.04%
-7.1%
Q2 2019$47,500,000
+17.3%
1,092,200
+2.7%
0.04%
+13.5%
Q1 2019$40,481,000
+164.8%
1,063,600
+199.4%
0.04%
+117.6%
Q4 2018$15,285,000
+318.5%
355,300
+378.2%
0.02%
+325.0%
Q3 2018$3,652,000
-84.3%
74,305
-85.4%
0.00%
-84.6%
Q4 2017$23,277,000
+65.5%
509,900
+36.2%
0.03%
+52.9%
Q3 2017$14,062,000
+1556.3%
374,500
+2003.9%
0.02%
+1600.0%
Q2 2017$849,000
+4.3%
17,800
-29.4%
0.00%0.0%
Q4 2016$814,000
-4.1%
25,200
+1.6%
0.00%
-50.0%
Q3 2016$849,000
-27.7%
24,800
-28.7%
0.00%0.0%
Q2 2016$1,174,000
-73.7%
34,800
-67.9%
0.00%
-81.8%
Q3 2015$4,459,000
+413.1%
108,500
+1007.1%
0.01%
+450.0%
Q4 2014$869,000
-77.5%
9,800
-75.4%
0.00%
-81.8%
Q3 2014$3,857,000
-67.9%
39,800
-76.8%
0.01%
-62.1%
Q1 2014$12,003,000
+192.0%
171,500
+139.9%
0.03%
+190.0%
Q4 2013$4,111,00071,5000.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Prosight Management, LP 1,210,377$37,134,36611.77%
Gagnon Advisors, LLC 180,331$5,532,5554.63%
GAGNON SECURITIES LLC 565,429$17,347,3614.35%
ARDSLEY ADVISORY PARTNERS LP 310,000$9,510,8002.12%
RICE HALL JAMES & ASSOCIATES, LLC 968,485$29,713,1201.89%
AlphaCentric Advisors LLC 103,000$3,160,0401.79%
1492 Capital Management LLC 79,687$2,444,7971.58%
ARDSLEY ADVISORY PARTNERS LP 149,000$4,571,3201.02%
OUTFITTER FINANCIAL LLC 32,305$991,1170.93%
Rock Springs Capital Management LP 1,055,500$32,382,7400.87%
View complete list of PACIRA PHARMACEUTICALS INC shareholders